(Q47993979)

7 February 2018

title

Display of heterologous antigens on the Bacillus subtilis spore coat using CotC as a fusion partner (English)

1 reference

7 February 2018

1 reference

7

1 reference

7 February 2018

Rachele Isticato

object named as

Rachele Isticato

3

0 references

author name string

Emilia M F Mauriello

1

1 reference

7 February 2018

Le H Duc

2

1 reference

7 February 2018

Giuseppina Cangiano

4

1 reference

7 February 2018

Huynh A Hong

5

1 reference

7 February 2018

Maurilio De Felice

6

1 reference

7 February 2018

Simon M Cutting

8

1 reference

7 February 2018

language of work or name

English

0 references

publication date

1 March 2004

1 reference

7 February 2018

published in

Vaccine

1 reference

7 February 2018

volume

22

1 reference

7 February 2018

issue

9-10

1 reference

7 February 2018

page(s)

1177-1187

1 reference

7 February 2018

Surface display of recombinant proteins on Bacillus subtilis spores.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.031

Bacterial spores as vaccine vehicles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.031

Gram-positive commensal bacteria for mucosal vaccine delivery.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.031

Mutants of Escherichia coli heat-labile toxin lacking ADP-ribosyltransferase activity act as nontoxic, mucosal adjuvants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.031

Expression of hepatitis B surface antigen in transgenic plants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.031

Resistance of Bacillus endospores to extreme terrestrial and extraterrestrial environments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.031

Genes encoding spore coat polypeptides from Bacillus subtilis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.031

Immunogenicity of the B monomer of Escherichia coli heat-labile toxin expressed on the surface of Streptococcus gordonii.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.031

Construction of a cloning site near one end of Tn917 into which foreign DNA may be inserted without affecting transposition in Bacillus subtilis or expression of the transposon-borne erm gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.031

Immunization with recombinant Streptococcus gordonii expressing tetanus toxin fragment C confers protection from lethal challenge in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.031

Oral vaccination of mice against tetanus with recombinant Lactococcus lactis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.031

Salivary antibodies and systemic tolerance in mice after oral immunization with bacterial antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.031

Assembly of multiple CotC forms into the Bacillus subtilis spore coat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.031

Gene encoding a morphogenic protein required in the assembly of the outer coat of the Bacillus subtilis endospore

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.031

Mucosal immunization against hepatitis B virus by intranasal co-administration of recombinant hepatitis B surface antigen and recombinant cholera toxin B subunit as an adjuvant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.031

Expression of tetanus toxin fragment C in yeast: gene synthesis is required to eliminate fortuitous polyadenylation sites in AT-rich DNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.031

Use of the nirB promoter to direct the stable expression of heterologous antigens in Salmonella oral vaccine strains: development of a single-dose oral tetanus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.031

Mechanisms for mucosal immunogenicity and adjuvancy of Escherichia coli labile enterotoxin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.031

Adjuvant activity of Escherichia coli heat-labile enterotoxin and effect on the induction of oral tolerance in mice to unrelated protein antigens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.031

Killed Campylobacter elicits immune response and protection when administered with an oral adjuvant.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.031

Oral immunization with the B subunit of the heat-labile enterotoxin of Escherichia coli induces early Th1 and late Th2 cytokine expression in Peyer's patches

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.031

Refined structure of Escherichia coli heat-labile enterotoxin, a close relative of cholera toxin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.031

Immune response induced by recombinant Mycobacterium bovis BCG producing the cholera toxin B subunit.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.031

The role of helper T cell products in mouse B cell differentiation and isotype regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.031

TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.031

Oral vaccination of mice against tetanus by use of a live attenuated Salmonella carrier.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.031

Immunization of mice against tetanus with fragments of tetanus toxin synthesized in Escherichia coli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.031

inferred from DOI database lookup

7 January 2021

based on heuristic

Oral vaccination against tetanus: comparison of the immunogenicities of Salmonella strains expressing fragment C from the nirB and htrA promoters.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.031

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2003.09.031

1 reference

7 February 2018

1 reference

7 February 2018